PATENT CLAIM ANALYSIS

Application Number: 16034046
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["530", "327000"]

Abstract:
The invention provides non-hormonal vitamin D conjugated via the third carbon on the vitamin D backbone to parathyroid hormone (PTH) proteins that result in increased absorption, bioavailability or circulating half-life when compared to non-conjugated forms.

Claim (Index 21):
The pharmaceutical composition of  claim 16 , wherein said protein stably attached to said scaffold and targeting group retains about the same activity as said protein not stably attached to said scaffold and targeting group as measured by a functional assay.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 95.0
- Lexical Diversity: 1.11429
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14919601', '14919572', '14919671', '14401519', '14542581']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7747539347584158
- 35 USC 102 Novelty (BERT): 0.6340352183595711
- Combined Prediction Score: 0.7606820631185314
- Mean Citation Score: 472.212292
- Max Citation Score: 637.79346
- Similarity Product: 544.2226810982752

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test